AGIO
Agios Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.
Market Cap: 4.5 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.agios.com
Shares Outstanding: 55.7 Million
Float: 55 Million
Dividend: 0.0 (0.0%)
Beta: 2.237777
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 6.72 Million
Ethical Flags
Longest drawdown: 1200 trading days
From: 2015-01-14 To: 2019-10-17
Lowest Point:
Key events next week - healthcare
via: SeekingAlpha at 2019-06-13 03:28:10:000
Noteworthy events during the week of June 16 - 22 for healthcare investors. More news on: ProMIS Neurosciences, Inc., Merck & Co., Inc., IQVIA Holdings Inc., Healthcare stocks news, , Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|